What Integrity Orthopaedics does

Integrity Orthopaedics is a privately-held medical device company founded in 2020 and headquartered in Maple Plain, Minnesota, that developed the Tendon Seam Rotator Cuff Repair System, an FDA 510(k)-cleared surgical platform for soft tissue repair. The system is built around patented micro-anchors (2mm diameter) used in greater density than traditional methods (6-12 anchors per repair versus an industry average of roughly 4), combined with a continuous locking stitch technique that runs perpendicular to tendon fibers, knotless compression, and integrated bone venting. The company markets this as a solution to the high structural failure rates (8-94%) of traditional rotator cuff repairs, claiming 2x the strength and 10x the stability of conventional approaches, 40% shorter case times, and the ability to reduce sling immobilization from approximately 6 weeks to a median of 2.5 weeks. The intellectual property stack derives from over 50 US patents originally developed at Rotation Medical and continued under co-founder and Chief IP Counsel David Crompton.

The company generated revenue exclusively through hardware sales of the Tendon Seam system to hospitals and surgical centers in the US market. Its go-to-market was a paced, enterprise field sales motion targeting orthopaedic surgeons and sports medicine specialists, supported by senior field clinical representatives and a surgeon onboarding portal. The customer base was concentrated in orthopaedic surgery practices performing rotator cuff repair (approximately 500,000 such procedures annually in the US, representing an $875 million market). Integrity raised a $20.6 million Series B in April 2024, co-led by Piper Sandler Merchant Banking, specifically to expand its US commercial launch. The company was acquired by Smith & Nephew in January 2026 for $225 million upfront plus up to $225 million in performance-based payments, and now operates within Smith & Nephew's Sports Medicine business unit alongside the REGENETEN Bioinductive Implant.

Name

Integrity Orthopaedics

Legal name

Integrity Orthopaedics, Inc.

Website

https://integrity-ortho.com

Company type

Private

Founded year

2020

Operating status

Acquired

Headcount range

11–50 employees

Short description

Integrity Orthopaedics developed the FDA-cleared Tendon Seam Rotator Cuff Repair System, a micro-anchor surgical platform addressing high failure rates in rotator cuff surgery, and was acquired by Smith & Nephew in January 2026.

Ownership category

akta.pro rank

Product category

Orthopaedic Surgical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industry

Orthopedic Surgery (Operative Orthopedics) (HLAKALAC)

Keywords

• Orthopaedic surgical devices
• Rotator cuff repair
• Soft tissue repair
• Sports medicine implants
• Minimally invasive surgery

Headquarters

HQ city

Maple Plain

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of the Tendon Seam Rotator Cuff Repair System to hospitals and surgical centers. The system is sold to orthopaedic surgeons performing rotator cuff repair procedures in the US market.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Integrity Orthopaedics develops and sells the Tendon Seam Rotator Cuff Repair System, a surgical medical device for soft tissue repair focused on rotator cuff procedures. The system uses patented 2mm micro-anchors, continuous locking stitches, and integrated bone venting to provide stronger, more stable rotator cuff repairs than traditional techniques. The device is FDA 510(k) cleared and sold to orthopaedic surgeons and hospitals performing the approximately 500,000 rotator cuff procedures performed annually in the US.

Product overview

Integrity Orthopaedics offers a single core product—the Tendon Seam™ Rotator Cuff Repair System—a surgical medical device designed to address the high failure rates (8-94%) associated with traditional rotator cuff repair techniques. The system enables robust initial repair strength while fostering an optimal environment for long-term healing, allowing patients to reduce sling immobilization from traditional 4-6 weeks to a median of 2.5 weeks. The company was acquired by Smith+Nephew in January 2026 and operates as part of their Sports Medicine business unit, complementing the existing REGENETEN Bioinductive Implant.

Differentiator

Problem solved

Functional benefit

Products and services

• Tendon Seam Rotator Cuff Repair System A next-generation rotator cuff repair system featuring patented 2mm PEEK micro-anchors, a continuous #2 UHMWPE locking stitch running perpendicular to tendon fibers, a patented anchor installation instrument, integrated bone venting, and knotless compression technology. FDA 510(k) cleared and sold to orthopaedic surgeons and hospitals performing rotator cuff repair procedures in the US market.

Quantifiable outcome

• Repair is 2X stronger than traditional methods on average
• +7 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Smith & Nephew (Post-Acquisition)coreStrategic or Co-development PartnerPost-acquisition, Integrity Orthopaedics operates within Smith & Nephew's Sports Medicine business unit. The companies plan to leverage Smith & Nephew's US commercial channels to accelerate adoption while building clinical evidence to support global expansion. The combination creates what Smith & Nephew claims is the most comprehensive shoulder repair portfolio available.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Arthrex: Arthrex is the largest privately-held sports medicine and orthopedic device company globally and a direct competitor in arthroscopic rotator cuff repair with its own suture anchor and passing systems. It is the most direct comparable to Integrity's Tendon Seam system in target customer (orthopedic surgeons) and product category (arthroscopic soft tissue repair).

Broad incumbents

• Smith & Nephew: Smith & Nephew is now Integrity's parent company following the Jan 2026 acquisition. Pre-acquisition, it was a broad incumbent in sports medicine via the REGENETEN Bioinductive Implant and other shoulder repair products, competing in the same rotator cuff repair market with an overlapping product portfolio.
• Stryker: Stryker is a major orthopedic medical device incumbent whose Sports Medicine division sells suture anchors and rotator cuff repair systems that compete directly with Tendon Seam. Josh Lee, Integrity's VP of Sales, came from Stryker Orthopaedics, further establishing the competitive overlap.
• Johnson & Johnson (DePuy Synthes Mitek Sports Medicine): J&J's Mitek Sports Medicine franchise offers a broad portfolio of arthroscopic shoulder repair products, including suture anchors and passing instruments, directly competing with Tendon Seam in the rotator cuff repair market.
• Zimmer Biomet: Zimmer Biomet is a global orthopedic device incumbent with a sports medicine portfolio including rotator cuff repair solutions that compete with Tendon Seam. Its large sales channel and GPO contracts overlap with Integrity's surgeon customer base.
• Conmed: Conmed has a sports medicine portfolio with arthroscopic shoulder repair devices and suture anchor systems that compete directly in the rotator cuff repair market. Its established US sales channel and hospital relationships are comparable to those Smith & Nephew will bring to Integrity.

Emerging players

• Integra LifeSciences: Integra LifeSciences has an orthopedic and sports medicine presence and develops regenerative and soft tissue repair technologies that partially overlap with Tendon Seam's tendon-to-bone repair application. It represents an emerging competitive threat in soft tissue repair innovation.
• Anika Therapeutics: Anika Therapeutics is a smaller orthopedic and regenerative medicine company developing viscosupplementation and soft tissue repair products. While smaller, it competes in adjacent orthopedic soft tissue repair segments with potential overlap to Tendon Seam's broader platform applications.
• Embody: Embody is an emerging medical device company focused on regenerative soft tissue repair, developing bioengineered collagen-based implants for tendon and ligament repair. It represents a partial overlap with Tendon Seam's tendon repair application, though its technology approach is different.

Regional players

• Paragon 28: Paragon 28 is a US-based orthopedic device company with a portfolio focused primarily on foot and ankle, though it has been expanding into adjacent orthopedic segments. Tom Schnettler (Piper Sandler, Integrity board) sits on Paragon 28's board, illustrating the broader orthopedic device ecosystem in which Integrity operates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/integrity-orthopaedics-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Integrity Orthopaedics